LFB BIOMANUFACTURING

manufactures monoclonal antibodies and recombinant proteins through cell culture

Cell line development

Process development and scale-up

Manufacturing of clinical and commercial batches

LFB BIOMANUFACTURING,

an LFB group company, is a CDMO

EMABling®,

our platform for monoclonal antibodies

Cutting-edge know how

Single use technologies

X 3 our production capacity increase

from 2017

The French State proposes Denis Delval as member of the Board in anticipation of his appointment as new LFB Group CEO

Upstream Technical Symposium, October 11, 2018

LFB Biomanufacturing will be present at BioTalk 2018 - Berlin September 20th 2018.

Inauguration of new industrial facilities at the LFB biotech plant in Alès